Cope; Frederick O.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cope; Frederick O..The latest application filed is for "compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same".

Company Profile

4.8.16

Cope; Frederick O. - Dublin OH
Cope; Frederick O. - Westerville OH
Cope; Frederick O - Dublin OH
Cope, Frederick O. - Columbus OH
Cope; Frederick O. - Worthington OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same Grant 11,369,680 - Cope June 28, 2	2022-06-28
Compounds And Compositions For Targeting Macrophages And Other Mannose-binding C-type Lectin Receptor High Expressing Cells And Methods Of Treating And Diagnosis Using Same App 20220062448 - COPE; Frederick O.	2022-03-03
Compositions, Methods And Kits For Diagnosing And Treating Cd206 Expressing Cell-related Disorders App 20220016272 - COPE; Frederick O. ; et al.	2022-01-20
Compositions And Methods For Diagnosing And Treating Macrophage-related Disorders Using Carbohydrate-based Macromolecular Carrier App 20210338848 - COPE; Frederick O.	2021-11-04
Compounds And Methods For Diagnosis And Treatment Of Viral Infections App 20210338827 - Cope; Frederick O. ; et al.	2021-11-04
Compounds And Compositions For Targeting Macrophages And Other Mannose-binding C-type Lectin Receptor High Expressing Cells And Methods Of Treating And Diagnosis Using Same App 20210275698 - COPE; Frederick O.	2021-09-09
Compounds and methods for diagnosis and treatment of viral infections Grant 11,007,272 - Cope , et al. May 18, 2	2021-05-18
Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis Grant 10,806,803 - Schlesinger , et al. October 20, 2	2020-10-20
Compositions And Methods For Assessing Macrophage Mediated Pathology App 20200237937 - Ralph; David A. ; et al.	2020-07-30
CD206+ Macrophage-Specific Molecular Imaging Probe Compositions and Methods and the Noninvasive Quantification of Arterial Wall Macrophage Infiltration in Humans App 20190021608 - Cope; Frederick O. ; et al.	2019-01-24
Use of 99mTc-tilmanocept and related molecular constructs for identifying and diagnosing malignant tumors and for monitoring therapeutic anti-tumor interventions App 20190022259 - Cope; Frederick O. ; et al.	2019-01-24
Compounds And Compositions For Treating Leishmaniasis And Methods Of Diagnosis And Treating Using Same App 20180099048 - Cope; Frederick O.	2018-04-12
Compositions And Methods For Diagnosing And Treating Macrophage-related Disorders Using Carbohydrate-based Macromolecular Carrier App 20180092998 - Cope; Frederick O	2018-04-05
Compounds And Compositions For Targeting Macrophages And Other Mannose-binding C-type Lectin Receptor High Expressing Cells And Methods Of Treating And Diagnosis Using Same App 20180015187 - Cope; Frederick O.	2018-01-18
Compounds And Compositions For Targeting Macrophages And Other Mannose-binding C-type Lectin Receptor High Expressing Cells And Methods Of Treating And Diagnosis Using Same App 20160206763 - Cope; Frederick O.	2016-07-21
Compositions, Methods And Kits For Diagnosing And Treating Cd206 Expressing Cell-related Disorders App 20150023876 - Cope; Frederick O. ; et al.	2015-01-22
Adult Stem Cells, Molecular Signatures, And Applications In The Evaluation, Diagnosis, And Therapy Of Mammalian Conditions App 20120270826 - Cope; Frederick O. ; et al.	2012-10-25
Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions App 20100003674 - Cope; Frederick O. ; et al.	2010-01-07
System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations App 20050036972 - Cope, Frederick O.	2005-02-17
Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy Grant 5,547,927 - Cope , et al. * August 20, 1	1996-08-20
Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy Grant 5,514,656 - Cope , et al. May 7, 1	1996-05-07
Method of providing enternal nutritional support to persons infected with human immunodeficiency virus Grant 5,480,872 - Cope , et al. * January 2, 1	1996-01-02
Nutritional product for persons infected with human immunodeficiency virus Grant 5,403,826 - Cope , et al. * April 4, 1	1995-04-04

Company Registrations

SEC

0001456549

Cope Frederick O

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.